Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- −6 vs. Q3 2023
- Shares held
- 182.9M
- −5.94M (−3.1%) vs. Q3 2023
- Total value
- $279.8M
- +$74.0M (+36.0%) vs. Q3 2023
- New holders
- 25
- 30 more added
- Sold out
- 31
- 24 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 2,382,286 | $3.64M | 0.24% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,043,291 | $4.66M | 0.00% | +228,257+8.1% | Added |
| Vanguard Group Inc | 5,980,371 | $9.15M | 0.00% | −419,840−6.6% | Reduced |
| BlackRock Inc. | 7,005,153 | $10.7M | 0.00% | +350,187+5.3% | Added |
| BVF Inc | 24,435,632 | $37.4M | 0.94% | +4,440,300+22.2% | Added |
| Artal Group S.A. | 117,553,284 | $179.9M | 6.13% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −1,923,076−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −1,136,413−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −509,484−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −469,666−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −378,701−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −310,815−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −277,248−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −242,300−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −192,398−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −145,746−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −137,735−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −91,700−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −62,243−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −62,077−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −42,834−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −34,844−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −31,372−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −30,937−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −29,615−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −29,558−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −29,470−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −22,800−100.0% | Sold out |
| Traynor Capital Management, Inc. | 0 | $0 | 0.00% | −21,909−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −20,787−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −16,493−100.0% | Sold out |
| Hudson Capital Management LLC | 0 | $0 | 0.00% | −15,038−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −14,239−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,595−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −4,635−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −2,049−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −184−100.0% | Sold out |